Documentaries, videos and podcasts
May 18, 2021
Longeveron Inc. (NASDAQ: LGVN) ("Longeveron" or "Company"), a clinical stage biotechnology company developing cellular therapies for chronic aging-related and life-threatening conditions, today announced the hiring of Dan Gincel, Ph.D. as Senior Vice President, Strategic Collaborations & Scientific Affairs.
Research and Markets
December 14, 2020
/PRNewswire/ -- The "Acute Respiratory Distress Syndrome (ARDS) Market Insight, Epidemiology and Market Forecast - 2030" report has been added to...
December 9, 2020
/PRNewswire/ -- All around the globe, scientists are working hard to develop effective treatments, therapies and vaccines to halt the COVID-19 pandemic....
Citius Pharmaceuticals, Inc.
December 8, 2020
/PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a specialty pharmaceutical company developing and commercializing...
December 8, 2020
Expanded Access Protocol on Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicle Infusion Treatment for Patients With COVID-19 Associated ARDS - Full Text View.
December 4, 2020
Treatment With Pirfenidone for COVID-19 Related Severe ARDS - Full Text View.
May 14, 2020
Relief Therapeutics and NeuroRx Announce Final Manufacturing Validation of RLF-100 for Phase 2b/3 Clinical Trial in Patients with COVID-19 Associated Acute Respiratory Distress Syndrome - read this article along with other careers information, tips and advice on BioSpace
May 8, 2020
Effectiveness and Safety of Convalescent Plasma Therapy on COVID-19 Patients With Acute Respiratory Distress Syndrome - Full Text View.
May 7, 2020
CORONA: A Study Using DeltaRex-G Gene Therapy for Symptomatic COVID-19 - Full Text View.
April 24, 2020
Hyperbaric Oxygen Therapy Effect in COVID-19 RCT (HBOTCOVID19) - Full Text View.
April 17, 2020
A Study to Assess the Efficacy and Safety of of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome Secondary to COVID-19. - Full Text View.
April 6, 2020
Tocilizumab in the Treatment of Coronavirus Induced Disease (COVID-19) - Full Text View.
Be the first contributor by making edits